FAKTOR-OPTIONSSCHEIN - E L Stock

Certificat

DE000MB47UW1

Market Closed - Bid/Ask 13:56:55 2024-07-05 EDT
0.39 EUR +2.63% Intraday chart for FAKTOR-OPTIONSSCHEIN - E L
1 month-11.63%
3 months-52.50%
Date Price Change
24-07-05 0.39 +2.63%
24-07-03 0.38 0.00%
24-07-02 0.38 0.00%
24-07-01 0.38 +8.57%
24-06-28 0.35 +6.06%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 01:56 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying E.L.F. BEAUTY, INC.
Issuer Morgan Stanley
WKN MB47UW
ISINDE000MB47UW1
Date issued 2023-03-08
Strike 303 $
Maturity Unlimited
Parity 241.91 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.62
Lowest since issue 0.33
Spread 0.01
Spread %2.50%

Company Profile

e.l.f. Beauty, Inc. is a multi-brand beauty company. The Company offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skincare products. The Company's family of brands includes e.l.f. Cosmetics, e.l.f. SKIN, Naturium, Well People and Keys Soulcare. Its e.l.f. SKIN is an ingredient-focused, dermatologist-developed formula for every eye, lip, face and skin concern. The Company operates across beauty categories including eye, lip, and face makeup, beauty tools and accessories, and skincare products. Its color cosmetics and skin care products are broadly sold through food, drug, and mass channels, as well as through department stores and direct and specialty channels. The Company's brands are available online and across beauty, mass market and specialty retailers in the United States and internationally. The Company sell its products online through its own direct e-commerce channels, as well as through other e-commerce Websites.
Sector
-
More about the company

Ratings for e.l.f. Beauty, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: e.l.f. Beauty, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
202 USD
Average target price
209.9 USD
Spread / Average Target
+3.91%
Consensus